Mechanism of hepatocellular dysfunction during hyperdynamic sepsis

American Journal of Physiology

Volumn 270, Issue 5 PART 2, 1996, Pages

  Wang, Ping ^a,b,c   Chaudry, Irshad H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; INTERLEUKIN 6; LIVER ENZYME; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DOSE RESPONSE; HEART OUTPUT; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER BLOOD FLOW; LIVER CELL DAMAGE; LIVER FAILURE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; SEPSIS; VASCULAR RESISTANCE;

ANIMALS; CARDIOVASCULAR SYSTEM; CYTOKINES; HEMODYNAMIC PROCESSES; HUMANS; INFECTION; LIVER; LIVER CIRCULATION;

EID: 0030004108     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.270.5.r927     Document Type: Article

References (126)

1. Alexander, J. W., S. T. Boyce, G. F. Babcock, L. Gianotti, M. D. Peck, D. L. Dünn, T. Pyles, C. P. Childress, and S. K. Ash. The process of microbial translocation. Ann. Surg. 212: 496-510,1990.
2. Ayala, A., M. M. Perrin, P. Wang, and I. H. Chaudry. Sepsis induces an early increased spontaneous release of the hepatocellular stimulatory factor (IL-6) by Kupffer cells in both endotoxin tolerant or intolerant mice. J. Surg. Res. 52: 635-641, 1992.
3. Bankey, P., A. Carlson, M. Ortiz, R. Singh, and F. Cerra. Tumor necrosis factor production by Kupffer cells requires protein kinase C activation. J. Surg. Res. 49: 256-261, 1990.
4. Barriere, S. L., and S. F. Lowry. An overview of mortality risk prediction in sepsis. Crit. Care Med. 23: 376-393,1995.
5. Baue, A. E. Multiple, progressive, or sequential systems failure: a syndrome of the 1970s. Arch. Surg. 110: 779-781, 1975.
6. Baue, A. E. Multiple organ failure, multiple organ dysfunction, and the systemic inflammatory response syndrome: where do we stand? Shock 2: 385-397,1994.
7. Bautista, A. P., A. Schuler, Z. Spolarics, and J. J. Spitzer. Tumor necrosis factor-a stimulates Superoxide anion generation by perfused rat liver and Kupffer cells. Am. J. Physiol. 261 (Gastrointest. Liver Physiol. 24): G891-G895, 1991.
8. Billiar, T. R., R. D. Curran, D. L. Williams, and P. H. Kispert. Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation. Arch. Surg. 127: 31-37, 1992.
9. Bone, R. C. Sepsis and its complications: the clinical problem. Crit. Care Med. 22: S8-S11,1994.
10. Breuille, D., M. C. Farge, F. Rose, M. Arnal, D. Attaix, and C. Obled. Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E660-E666, 1993.
11. Burczynski, F. J., and C. V. Greenway. Hepatic blood flow: accuracy of estimation from galactose clearances in cats. Can. J. Physiol. 64: 1310-1315, 1986.
12. Busund, R., R.-O. Lindsetmo, L.-T. Rasmussen, O. Rokke, O. P. Rekvig, and A. Revhaug. Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion. Arch. Surg. 126: 591-597,1991.
13. Byerley, L. O., N. W. Alcock, and H. F. Starnes, Sepsisinduced cascade of cytokine mRNA expression: correlation with metabolic changes. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E728-E735, 1992.
14. Gallery, M. P., T. Kamei, and W. Flye. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch. Surg. 125: 36-40, 1990.
15. Gallery, M. P., T. Kamei, M. J. Mangino, and M. W. Flye. Organ interactions in sepsis. Host defense and the hepaticpulmonary macrophage axis. Arch. Surg. 126: 28-32, 1991.
16. Cannon, J. G., R. G. Tompkins, J. A. Gelfand, H. R. Michie, G. G. Stanford, J. W. M. Van Der Meer, S. Endres, G. Lonnemann, J. Corsetti, B. Chernow, D. W. Wilmore, S. M. Wolff, J. F. Burke, and C. A. Dinarello. Circulating interleukin-1 and tumor necrosis factor in septic shock, and experimental endotoxin fever. J. Infect. Dis. 161: 79-84,1990.
17. Carroll, G. C., and J. V. Snyder. Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am. J. Physiol. 243 (Regulatory Integrative Comp. Physiol. 12):R131-R141, 1982.
18. Chalkiadakis, G. E., A. Kostakis, P. E. Karayannacos, M. E. Chalkiadakis, S. Sgouromali, H. Giamarellou, and G. D. Skalkeas. Pentoxifylline in the treatment of experimental peritonitis in rats. Arch. Surg. 120: 1141-1144, 1985.
19. Chaudry, I. H. Cellular mechanisms in shock and ischemia and their correction. Am. J. Physiol. 245 (Regulatory Integrative Comp. Physiol. 14): R117-R134, 1983.
20. Chaudry, I. H., and A. Ayala. Immunological Aspects of Hemorrhage. Austin, TX: Medical Intelligence Unit, Landes, 1992, p. 1-132.
21. Chaudry, I. H., A. Ayala, G. Singh, P. Wang, and J. G. Hauptman. Rodent models of endotoxemia and sepsis. In: Pathophysiology of Shock, Sepsis, and Organ Failure, edited by G. Schlag and H. Redl. Berlin: Springer-Verlag, 1993, p. 10481059.
22. Chaudry, I. H., S. Schleck, M. G. Clemens, T. E. Kupper, and A. E. Baue. Altered hepatocellular active transport. An early change in peritonitis. Arch. Surg. 117: 151-157, 1982.
23. Chaudry, I. H., K. A. Wichterman, and A. E. Baue. Effect of sepsis on tissue adenine nucleotide levels. Surgery 85: 205-211, 1979.
24. Chensue, S. W., P. D. Tercbuh, D. G. Remick, W. E. Scales, and S. L. Kunkel. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, glucocorticoid effects. Am. J. Pathol. 138: 395-402,1991.
25. Cryer, H. G., R. N. Garrison, P. D. Harris, B. H. Greenwald, and N. L. Alsip. Prostaglandins mediate skeletal muscle arteriole dilation in hyperdynamic bacteremia. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H728-H734, 1990.
26. Dahn, M. S., C. J. Hsu, M. P. Lange, and L. S. Jefferson. Effects of tumor necrosis factor- on glucose and albumin production in primary cultures of rat hepatocytes. Metabolism 43: 476-480,1994.
27. Dahn, M. S., M. P. Lange, R. F. Wilson, L. A. Jacobs, and R. A. Mitchell. Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis. Surgery 107: 295-301,1990.
28. Dahn, M. S., R. F. Wilson, P. Lange, A. Stone, and L. A. Jacobs. Hepatic parenchymal oxygen tension following injury and sepsis. Arch. Surg. 125: 441-443, 1990.
29. Debets, J. M. H., R. Kampmeijer, M. P. M. H. Van Der Linden, W. A. Buurman, and C. J. Van Der Linden. Plasma tumor necrosis factor and mortality in critically ill septic patients. Grit. Care Med. 17: 489-494,1989.
30. Deitch, E. A., L. Ma, W. J. Ma, M. B. Grisham, D. N. Granger, R. D. Specian, and R. D. Berg. Inhibition of endotoxin-induced bacterial translocation in mice. J. Clin. Invest. 84: 36-42, 1989.
31. Emerson, T. E., Jr., D. C. Lindsey, G. J. Jesmok, M. L. Duerr, and M. A. Fournel. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ. Shock 38: 75-84,1992.
32. Ertel, W., M. H. Morrison, P. Wang, Z. F. Ba, A. Ayala, and I. H. Chaudry. The complex pattern of cytokines in sepsisassociation between prostaglandins, cachectin and interleukins. Aren. Surg. 214: 141-148,1991.
33. Espevik, T., and K. Nissen-Meyer. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105,1986.
34. Fiedler, V. B., I. Loof, E. Sander, V. Voehringer, C. Galanos, and M. A. Fournel. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J. Lab. Clin. Med. 120: 574-588,1992.
35. Fink, M. P., and S. O. Heard. Laboratory models of sepsis and septic shock. J. Surg. Res. 49: 186-196,1990.
36. Fish, R. E., and J. A. Spitzer. Continuous infusion of endotoxin from an osmotic pump in the conscious, unrestrained rat: a unique model of chronic endotoxemia. Circ. Shock 12: 135149, 1984.
37. Fong, Y., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. B. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A. C. Allison, S. F. Lowry, and A. Cerami. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170: 16271633,1989.
38. Fry, D. E., B. B. Silver, R. D. Rink, L. R. Vanarsdall, and L. M. Flint, Hepatic cellular hypoxia in murine peritonitis. Surgery 85: 652-661, 1979.
39. Furutani, M., S. Arii, K. Monden, Y. Adachi, N. Funaki, H. Higashitsuji, S. Fujita, M. Mise, S. Ishiguro, T. Kitao, T. Nakamura, M. Imamura, T. Tamatani, M. Miyasaka, H. Nakayama, and J. Fujita. Immunologie activation of hepatic macrophages in septic rats: a possible mechanism of sepsis-associated liver injury. J. Lab. Clin. Med. 123: 430-436, 1994.
40. Garrison, R. N., D. J. Ratcliff, and D. E. Fry. Hepatocellular function and nutrient blood flow in experimental peritonitis. Surgery 92: 713-719, 1982.
41. Ge, Y., R. M. Ezzel, R. G. Tompkins, and H. S. Warren. Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria. J. Infect. Dis. 169: 95-104, 1994.
42. Girardin, E., J. M. Grau, J. M. Dayer, P. Roux-Lombard, the J5 Study Group, and P. H. Lambert. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319: 397-400, 1988.
43. Goodman, M. N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E727-E730,1991.
44. Gottlieb, M. E., H. H. Stratton, J. C. Newell, and D. M. Shah. Indocyanine green: its use as an early indicator of hepatic dysfunction following injury in man. Arch. Surg. 119: 264-268,1984.
45. Hadjiminas, D. J., K. M. McMasters, J. C. Peyton, and W. G. Cheadle. Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. J. Surg. Res. 56: 549-555, 1994.
46. Hampton, W. A., M. D. Townsend, D. M. Haybron, W. J. Shirmer, and D. E. Fry. Effective hepatic blood flow and hepatic bioenergy status in murine peritonitis. J. Surg. Res. 42: 33-38,1987.
47. Hasselgren, P.-O. Protein Metabolism in Sepsis. Austin, TX: Landes, 1993, p. 1-130.
48. Hauptman, J. G., G. K. Dejong, K. A. Blasko, and I. H. Chaudry. Measurement of hepatocellular function, cardiac output, effective blood volume, and oxygen saturation in the rat. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R439-R444, 1989.
49. Hauptman, J. G., P. Wang, G. K. Dejong, and I. H. Chaudry. Improved methodology for the evaluation of the velocity of clearance of indocyanine green in the rat. Circ. Shock 32: 26-32, 1991.
50. Heimburger, S. L., W. S. McDougal, D. W. Wilmore, and B. A. Pruitt, Correction of hepatocellular dysfunction during endotoxemia. J. Surg. Res. 24: 442-448,1978.
51. Hesse, D. G., K. J. Tracey, Y. Fong, K. R. Manogue, M. A. Palladino, A. Cerami, G. T. Shires, and S. F. Lowry. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166: 147-153, 1988.
52. Hoffmann, R., M. Grewe, H. C. Estler, A. SchulzeSpecking, and K. Decker. Regulation of tumor necrosis factor-alpha mRNA synthesis and distribution of tumor necrosis factor-alpha-mRNA synthesizing cells in rat liver during experimental endotoxemia. J. Hepatol. 20: 122-128,1994.
53. Hultner, L., M. Szots, M. Welle, J. Moeller, and P. Dormeu. Mouse bone marrow-derived interleukin-3-dependent mast cells and autonomous sublines produce interleukin-6. Immunology 67: 408-413,1989.
54. Hwang, T. L., Y. T. Lau, S. F. Huang, M. F. Chen, and M. S. Liu. Changes of a-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology 20: 638-642,1994.
55. Inaba, H., M. Araki, and T. Numai. Modulation of protein kinase C alters hemodynamics and metabolism in the isolated liver in fed and fasted rats. J. Hepatol. 19: 475-484,1993.
56. Kaplowitz, N. Physiological significance of glutathione Stransferases. Am. J. Physiol. 239 (Gastrointest. Liver Physiol. 2): G439-G444,1980.
57. Klosterhalfen, B., K. Horstmann-Jungemann, P. Vogel, G. Dufhues, B. Simon, G. Kalff, C. J. Kirkpatrick, C. Mittermayer, and P. C. Heinrich. Hemodynamic variables and plasma levels of PGI2, TXA2 and IL-6 in a porcine model of recurrent endotoxemia. Circ. Shock 35: 237-244, 1991.
58. Kopprasch, S., U. Horkner, H. Orlik, C. Kemmer, and D. W. Scheuch. Energy state, glycolytic intermediates and mitochondrial function in the liver during reversible and irreversible endotoxin shock. Biomed. Biochim. Acta 48: 653-659, 1989.
59. Lang, C. H. Sepsis-induced insulin resistance in rats is mediated by a -adrenergic mechanism. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E703-E711, 1992.
60. Lang, C. H., G. J. Bagby, G. H. Bornside, L. J. Vial, and J. J. Spitzer. Sustained hypermetabolic sepsis in rats: characterization of the model. J. Surg. Res. 35: 201-210, 1983.
61. Lang, C. H., G. J. Bagby, J. L. Ferguson, and J. J. Spitzer. Cardiac output and redistribution of organ blood flow in hypermetabolic sepsis. Am. J. Physiol. 246 (Regulatory Integrative Comp. Physiol. 15): R331-R337, 1984.
62. Leevy, C. M., C. B. Leevy, and M. M. Howard. Indocyanine green and the liver. In: Problems in Liver Diseases, edited by C. S. Davidson. New York: Stratton Intercontinental Medical Book, 1979, p. 42-52.
63. Levi, A. J., Z. Gatmaitan, and I. M. Arias. Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J. Clin. Invest. 48: 2156-2167, 1969.
64. Limuro, Y., M. Yamamoto, H. Kohno, J. Itakura, H. Fujii, and Y. Mat sumo to. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats-analysis of mechanisms of lethality in endotoxemia. J. Leukocyte Biol. 55: 723-728, 1994.
65. Liu, M.-S. Mechanisms of myocardial membrane alterations in endotoxin shock: roles of phospholipase, and phosphorylation. Circ. Shock 30: 43-49, 1990.
66. Luster, M. I., D. R. Germolec, T. Yoshida, F. Kayama, and M. Thompson. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19: 480-488, 1994.
67. Machiedo, G. W., T. Hurd, B. R. Rush, G. Dikdan, J. McGee, and T. Lysz. Temporal relationship of hepatocellular dysfunction and ischemia in sepsis. Arch. Surg. 123: 424427,1988.
68. Marano, M. A., Y. Fong, L. L. Moldawer, H. Wei, S. E. Galvano, K. J. Tracey, P. S. Barie, K. Manogue, A. Cerami, G. T. Shires, and S. F. Lowry. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol. Obstet. 170: 32-38, 1990.
69. Marks, J. D., C. B. Marks, J. M. Luce, B. Montgomery, J. Turner, C. A. Metz, and J. F. Murray. Plasma tumor necrosis factor in patients with septic shock. Am. Rev. Respir. Dis. 141:94-97, 1990.
70. Mela-Riker, L., P. Alexander, D. Bartos, R. E. Bryant, R. S. Connell, L. Erwin, B. Gilchrist, M. Harrison, D. Luallin, G. Oh, and L. Widener. Chronic hyperdynamic sepsis in the rat: I. Characterization of the animal model. Circ. Shock 25: 231-244, 1988.
71. Michie, H. R., D. R. Spriggs, K. R. Manogue, M. L. Sherman, A. Revhaug, S. T. O'Dwyer, K.Arthur, C. A. Dinarello, A. Cerami, S. M. Wolff, D. W. Kufe, and D. W. Wilmore. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104: 280-286, 1988.
72. Monden, K., S. Arii, S. Itai, T. Sasaoki, Y. Adachi, N. Funaki, H. Higashitsuji, and T. Tobe. Enhancement and hepatocyte-modulating effect of chemical mediators and monokines produced by hepatic macrophages in rats with induced sepsis. Res. Exp. Med. 191: 177-187, 1991.
73. Monden, K., S. Arii, S. Itai, T. Sasaoki, Y. Adachi, N. Funaki, and T. Tobe. Enhancement of hepatic macrophages in septic rats and their inhibitory effect on hepatocyte function. J. Surg. Res. 50: 72-76, 1991.
74. Moody, F. G., L. F. Rikkers, and J. S. Aldrete. Estimation of the functional reserve of human liver. Ann. Surg. 180: 592-598, 1974.
75. Müllen, P. G., B. J. Fisher, C. J. Walsh, B. M. Susskind, S. K. Leeper-Woodford, G. J. Jesmok, A. A. Fowler, and H. J. Sugerman. Monoclonal antibody tumor necrosis factor- attenuates plasma interleukin-6 levels in porcine Gramnegative sepsis. J. Surg. Res. 57: 625-631, 1994.
76. Noshima, S., H. Noda, D. N. Herndon, L. D. Traber, and D. L. Traber. Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep. J. Appl. Physiol. 74: 1528-1533, 1993.
77. O'Neill, P. J., A. Ayala, P. Wang, Z. F. Ba, M. H. Morrison, A. E. Schultze, S. S. Reich, and I. H. Chaudry. Role of Kupffer cells in interleukin-6 release following trauma-hemorrhage and resuscitation. Shock 1: 43-47, 1994.
78. O'Riordain, M. G., K. H. Collins, M. Pilz, I. B. Saporoschetz, J. A. Mannick, and M. L. Rodrick. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch. Surg. 127: 152-158, 1992.
79. Oka, Y., A. Murata, J. Nishijima, M. Ogawa, and T. Mori. The mechanism of hepatic cellular injury in sepsis: an in vitro study of the implications of cytokines and neutrophils in its pathogenesis. J. Surg. Res. 55: 1-8, 1993.
80. Paumgartner, G., P. Probst, R. Kraines, and C. M. Leevy. Kinetics of indocyanine green removal from the blood. Ann. NY Acad. Sei. 170: 134-147, 1970.
81. Pedersen, P., A. Saljo, and P. O. Hasselgren. Protein and energy metabolism in liver tissue following intravenous infusion of liver E. coli bacteria in rats. Circ. Shock 21: 59-64, 1987.
82. Pinsky, M. R., J. L. Vincent, J. Deviere, M. Alegre, R. J. Kahn, and E. Dupont. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103: 565-575, 1993.
83. Pollack, G. M., K. L. R. Brouwer, K. B. Demby, and J. A. Jones. Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose. Drug Metab. Dispos. 18: 197-202, 1990.
84. Rikkers, L. F., and F. G. Moody. Estimation of functional hepatic mass in resected and regenerating rat liver. Gastroenterology 67: 691-699,1974.
85. Rose, S., K. D. Thompson, and M. M. Sayeed. Ca2 -related hepatocellular alterations during intra-abdominal sepsis. Am. J. Physiol. 263 (Regulatory Integrative Cornp. Physiol. 32): R553R558, 1992.
86. Rudolf, R., J. Cavanilles, S. Michaels, H. Shubin, and M. H. Weil. Disappearance of indocyanine green during circulatory shock. Sarg. Gynecol. Obstet. 136: 57-62, 1973.
87. Sayeed, M. M. Alterations in cellular calcium regulation in the liver in endotoxic shock. Am. J. Physiol. 250 (Regulatory Integrative Comp. Physiol. 19): R884-R891, 1986.
88. Schiffer, E. R., G. Mentha, I. M. Schwieger, and D. R. Morel. Sequential changes in the splanchnic circulation during continuous endotoxin infusion in sedated sheep: evidence for a selective increase of hepatic artery blood flow and loss of the hepatic arterial buffer response. Acta Physiol. Scand. 147: 251-261,1993.
89. Schirmer, W. J., J. M. Schirmer, and D. E. Fry. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch. Surg. 124: 445-448, 1989.
90. Schlag, G., H. Redl, J. Davies, and I. Haller. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock 2: 10-18, 1994.
91. Schlag, G., H. Redl, S. Hallsrom, K. Radmore, and J. Davies. Hyperdynamic sepsis in baboons: I. Aspects of hemodynamics. Circ. Shock 34: 311-318, 1991.
92. Schregel, W., H.-D. Kuntz, and M. Vit. Hepatic drug disposition in multiple organ failure. Acta Anaesthesiol. Scand. 32: 638-642, 1988.
93. Shalaby, M. R., A. Waage, and T. Espevik. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53: 488498, 1989.
94. Shiratori, Y., H. Kiriyama, Y. Fukushi, T. Nagura, H. Takada, K. Hai, and K. Kamii. Modulation of ischemiareperfusion-induced hepatic injury by Kupffer cells. Dig. Dis. Sei. 39:1265-1272,1994.
95. Stahl, T. J., P. B. Alden, W. S. Ring, R. C. Madoff, and F. B. Cerra. Sepsis-induced diastolic dysfunction in chronic peritonitis. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H625-H633, 1990.
96. Townsend, M. C., W. W. Hampton, D. M. Haybron, W. J. Schirmer, and D. E. Fry. Effective organ blood flow and bioenergy status in murine peritonitis. Surgery 100: 205-213, 1986.
97. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, G. R. Shires, and A. Cerami. Shock, and tissue injury induced by recombinant human cachectin. Science Wash. DC 234: 470-474, 1986.
98. Tuchschmidt, J., J. Fried, M. Astiz, and E. Rackow. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 102: 216-220, 1992.
99. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo. Proc. Natl. Acad. Sei. USA 89: 4845-4849, 1992.
100. Vara, E., J. Arias-Diaz, J. Torres-Melero, C. Garcia, J. M. Rodriguez, and J. L. Balibrea. Effect of different sepsisrelated cytokines on lipid synthesis by isolated hepatocytes. Hepatology 20: 924-931,1994.
101. Von Allmen, D., S. J. Li, P. O. Hasselgren, and J. E. Fischer. Effect of ischemia on protein synthesis in the septic liver. Surg. Gynecol. Obstet. 172:441-448, 1991.
102. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169: 333-338,1989.
103. Waage, A., A. Halstensen, and T. Espevik. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355-357, 1987.
104. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Kierulf, and T. Espevik. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. J. Exp. Med. 170: 1859-1867,1989.
105. Walsh, C. J., H. J. Sugerman, P. G. Müllen, P. D. Carey, S. K. Leeper-Woodford, G. J. Jesmok, E. F. Ellis, and A. A. Fowler. Monoclonal antibody to tumor necrosis factor a attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis. Arch. Surg. 127: 138-145,1992.
106. Walvatne, C., and F. B. Cerra. Hepatic dysfunction in multiple organ failure. In: Multiple Organ Failure: Pathophysiology and Basic Concepts of Therapy, edited by E. A. Deitch. New York: Thieme Medical Publishers, 1990, p. 241-260.
107. Wang, P., A. Ayala, Z. F. Ba, M. Zhou, M. M. Perrin, and I. H. Chaudry. Tumor necrosis factor-a produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G126-G132,1993.
108. Wang, P., Z. F. Ba, A. Ayala, and I. H. Chaudry. Hepatocellular dysfunction persists during early sepsis despite increased volume of crystalloid resuscitation. J. Trauma 32: 389-397, 1992.
109. Wang, P., Z. F. Ba, J. Burkhardt, and I. H. Chaudry. Measurement of hepatic blood flow after severe hemorrhage: lack of restoration despite adequate resuscitation. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G92-G98,1992.
110. Wang, P., Z. F. Ba, and I. H. Chaudry. Hepatic extraction of indocyanine green is depressed early in sepsis despite increased hepatic blood flow and cardiac output. Arch. Surg. 126: 219224, 1991.
111. Wang, P., Z. F. Ba, and I. H. Chaudry. Increase in hepatic blood flow during early sepsis is due to increased portal blood flow. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30):R1507-R1512,1991.
112. Wang, P., Z. F. Ba, and I. H. Chaudry. Nitric oxide: to block or enhance its production during sepsis? Arch. Surg. 129: 11371143,1994.
113. Wang, P., Z. F. Ba, and I. H. Chaudry. Administration of tumor necrosis factor-a in vivo depresses endothelium-dependent relaxation. Am. J. Physiol. 266 (Heart Cire. Physiol. 35): H2535-H2541,1994.
114. Wang, P., Z. F. Ba, and I. H. Chaudry. Hepatocellular dysfunction occurs earlier than the onset of hyperdynamic circulation during sepsis. Shock 3: 21-26, 1995.
115. Wang, P., Z. F. Ba, M.-C. Lu, A. Ayala, J. M. Harkema, and I. H. Chaudry. Measurement of circulating blood volume in vivo after trauma-hemorrhage and hemodilution. Am. J. Physiol. 266 (Regulatory Integratiue Comp. Physiol. 35): R368-R374, 1994.
116. Wang, P., Z. F. Ba, S. M. Tait, M. Zhou, and I. H. Chaudry. Alterations in circulating blood volume during polymicrobial sepsis. Circ. Shock 40: 92-98,1993.
117. Wang, P., and I. H. Chaudry. Crystalloid resuscitation restores but does not maintain cardiac output following severe hemorrhage. J. Surg. Res. 50: 163-169,1991.
118. Wang, P., J. G. Hauptman, and I. H. Chaudry. Hepatocellular dysfunction occurs early after hemorrhage and persists despite fluid resuscitation. J. Surg. Res. 48: 464-470, 1990.
119. Wang, P., G. Singh, M. W. Rana, Z. F. Ba, and I. H. Chaudry. Preheparinization improves organ function after hemorrhage and resuscitation. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R645-R650,1990.
120. Wang, P., M. Zhou, M. W. Rana, Z. F. Ba, and I. H. Chaudry. Differential alterations in microvascular perfusion in various organs during early and late sepsis. Am. J. Physiol. 263 (Gastrointest. Liver Physiol. 26): G38-G43,1992.
121. Warren, R. S., H. F. Starnes, Jr., N. Alcock, S. Calvano, and M. F. Brennan. Hormonal and metabolic response to recombinant human tumor necrosis factor in rat: in vitro and in vivo. Am. J. Physiol. 255 (Endocrinol. Metab. 18): E206-E212, 1988.
122. Wells, C. L., R. G. Barton, C. S. Wavatne, D. L. Dünn, and F. B. Cerra. Intestinal bacterial flora, intestinal pathology, and lipopolysaccharide-induced translocation of intestinal bacteria. Circ. Shock 37: 117-123, 1992.
123. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. Sepsis and septic shock-a review of laboratory models and a proposal. J. Surg. Res. 29:189-201,1980.
124. Witek-Janusek, L., and J. K. Ratmeyer. Sepsis in the young rat: maternal milk protects during cecal ligation and puncture sepsis but not during endotoxemia. Circ. Shock 33: 200-206, 1991.
125. Yelich, M. R. Glucoregulatory, hormonal, and metabolic responses to endotoxicosis or cecal ligation and puncture sepsis in the rat: a direct comparison. Circ. Shock 31: 351-363,1990.
126. Yoshida, M., J. Tanaka, J. Tamura, K.-I. Fujita, T. Kasamatsu, M. Kohmoto, and T. Kaido. Significance of altered fluidity of plasma membranes of the liver and kidney in rats with sepsis. J. Surg. Res. 58: 131-136,1995.